We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cequent Files its First IND with FDA for a tkRNAi Drug Candidate, CEQ508

News   Nov 16, 2009

 
Cequent Files its First IND with FDA for a tkRNAi Drug Candidate, CEQ508
 
 
 

RELATED ARTICLES

Aging in Older Mice Delayed by Giving Enzyme From Younger Mice

News

New research has identified a novel approach to staving off the detrimental effects of aging in mice.

READ MORE

Quality Assurance Step in Gene Expression Clarified in Yeast

News

Removal of introns from pre-mRNAs is an essential step in eukaryotic gene expression. Using yeast, researchers provided new insights on this evolutionarily conserved quality assurance step.

READ MORE

Chemists Synthesize > 1 Million Macrocycles for Drug Discovery

News

Chemists from the University of Basel have built a rich collection of natural product-like macrocycles that can be mined for new medicines as the researchers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE